Nosocomial Infections in In-hospital Cardiac Arrest Patients Who Undergo Extracorporeal Cardiopulmonary Resuscitation

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Dec 28

PMID 33362276

Citations 11

Authors

Ryoung-Eun Ko

Kyungmin Huh

Dong-Hoon Kim

Soo Jin Na

Chi Ryang Chung

Yang Hyun Cho

Kyeongman Jeon

Gee Young Suh

Jeong Hoon Yang

Affiliations

Soon will be listed here.

Abstract

Background: Little is known of nosocomial infections (NI) in patients who suffer from in-hospital cardiac arrest who undergoing extracorporeal cardiopulmonary resuscitation. This study aimed to investigate clinical pictures of NI, and the association of NIs with clinical outcomes in in-hospital cardiac arrest patients who undergoing extracorporeal cardiopulmonary resuscitation.

Methods: To evaluate the incidence and clinical characteristics of NI in patients who undergoing extracorporeal cardiopulmonary resuscitation, a retrospective cohort study was conducted in a single tertiary referral center between January 2010 and December 2018. We included adult patients who undergoing extracorporeal cardiopulmonary resuscitation for in-hospital cardiac arrest and excluded patients who were out-of-hospital cardiac arrest or failed ECMO implantation. Clinical characteristics and outcomes were compared between NI and Non-NI patients, or multidrug-resistant (MDR) and non-MDR. The independent risk factors associated with NIs were also analyzed using multivariable logistic regression model.

Results: Thirty-five (23.3%) patients developed a NI. These cases included 21 patients with a gram negative (G-) infection, 12 patients with a gram positive (G+) bacterial infection, and two patients with fungal infection. Pneumonia was the most common type of NIs, followed by catheter-related infection. The in-hospital mortality and neurologic outcomes at discharge were not different between the NI and non-NI groups. Multidrug-resistant (MDR) pathogens were detected in 10 cases (28.6%). The MDR NI patients had a higher ICU mortality than did those with non-MDR NI (80% vs. 32%, p = 0.028). Following multivariable adjustment, body mass index (adjusted OR 0.87, 95% CI, 0.77-0.97, p = 0.016) and cardiopulmonary resuscitation to pump on time (adjusted OR 1.04, 95% CI, 1.01-1.06, p = 0.001) were independent predictors of NI development.

Conclusions: In patients who received extracorporeal cardiopulmonary resuscitation, NIs were not associated with an increase in in-hospital mortality. However, NIs with MDR organisms do increase the risk of in-hospital mortality. Lower body mass index and longer low flow time were significant predictors of NI development.

Citing Articles

Risk factors for nosocomial infection in patients undergoing extracorporeal membrane oxygenation support treatment: A systematic review and meta-analysis.

Lv X, Han Y, Liu D, Chen X, Chen L, Huang H PLoS One. 2024; 19(11):e0308078.

PMID: 39585868 PMC: 11588223. DOI: 10.1371/journal.pone.0308078.

Landscape of the immune infiltration and identification of molecular diagnostic markers associated with immune cells in patients with kidney transplantation.

Xu Z, Sun X, Ma X, Tao B, Wu J, He Y Sci Rep. 2024; 14(1):24770.

PMID: 39433868 PMC: 11493967. DOI: 10.1038/s41598-024-75052-6.

Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis.

Ait Hssain A, Vahedian-Azimi A, Saif Ibrahim A, Fawzy Hassan I, Azoulay E, Darmon M Crit Care. 2024; 28(1):158.

PMID: 38730424 PMC: 11088079. DOI: 10.1186/s13054-024-04946-8.

Prophylactic antibiotic treatment for preventing nosocomial infection in extracorporeal membrane oxygenation-resuscitated circulatory arrest patients.

Kuo L, Wang Y, Chen P, Lin W, Wang W, Shih C JTCVS Open. 2024; 16:582-601.

PMID: 38204699 PMC: 10774957. DOI: 10.1016/j.xjon.2023.06.024.

Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body: A Multicenter, Prospective Observational Study.

Trummer G, Benk C, Pooth J, Wengenmayer T, Supady A, Staudacher D J Clin Med. 2024; 13(1).

PMID: 38202063 PMC: 10780178. DOI: 10.3390/jcm13010056.

References

Parker C, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day A . Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care. 2008; 23(1):18-26. DOI: 10.1016/j.jcrc.2008.02.001. View

Ryu J, Chung C, Cho Y, Sung K, Suh G, Park T . The association of findings on brain computed tomography with neurologic outcomes following extracorporeal cardiopulmonary resuscitation. Crit Care. 2017; 21(1):15. PMC: 5264281. DOI: 10.1186/s13054-017-1604-6. View

Huh K, Chung D, Park H, Kim M, Lee N, Ha Y . Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance. Am J Infect Control. 2016; 44(9):e145-52. DOI: 10.1016/j.ajic.2016.01.025. View

Neumar R, Shuster M, Callaway C, Gent L, Atkins D, Bhanji F . Part 1: Executive Summary: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015; 132(18 Suppl 2):S315-67. DOI: 10.1161/CIR.0000000000000252. View

Ko R, Ryu J, Cho Y, Sung K, Jeon K, Suh G . The differential neurologic prognosis of low-flow time according to the initial rhythm in patients who undergo extracorporeal cardiopulmonary resuscitation. Resuscitation. 2020; 148:121-127. DOI: 10.1016/j.resuscitation.2020.01.015. View

Biffi S, Di Bella S, Scaravilli V, Peri A, Grasselli G, Alagna L . Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. Int J Antimicrob Agents. 2017; 50(1):9-16. DOI: 10.1016/j.ijantimicag.2017.02.025. View

Na S, Chung C, Choi H, Cho Y, Sung K, Yang J . The effect of multidisciplinary extracorporeal membrane oxygenation team on clinical outcomes in patients with severe acute respiratory failure. Ann Intensive Care. 2018; 8(1):31. PMC: 5826909. DOI: 10.1186/s13613-018-0375-9. View

Vogel A, Lew D, Kao L, Lally K . Defining risk for infectious complications on extracorporeal life support. J Pediatr Surg. 2011; 46(12):2260-4. DOI: 10.1016/j.jpedsurg.2011.09.013. View

Mermel L, Allon M, Bouza E, Craven D, Flynn P, OGrady N . Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(1):1-45. PMC: 4039170. DOI: 10.1086/599376. View

10.

Bizzarro M, Conrad S, Kaufman D, Rycus P . Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med. 2010; 12(3):277-81. DOI: 10.1097/PCC.0b013e3181e28894. View

11.

Ryu J, Cho Y, Sung K, Choi S, Yang J, Choi J . Predictors of neurological outcomes after successful extracorporeal cardiopulmonary resuscitation. BMC Anesthesiol. 2015; 15:26. PMC: 4358703. DOI: 10.1186/s12871-015-0002-3. View

12.

Vincent J, Bihari D, Suter P, Bruining H, White J, Wolff M . The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995; 274(8):639-44. View

13.

Hooton T, Bradley S, Cardenas D, Colgan R, Geerlings S, Rice J . Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50(5):625-63. DOI: 10.1086/650482. View

14.

Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E . Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrob Agents Chemother. 2016; 60(8):4840-52. PMC: 4958232. DOI: 10.1128/AAC.00825-16. View

15.

Thomas G, Hraiech S, Cassir N, Lehingue S, Rambaud R, Wiramus S . Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections. Ann Intensive Care. 2017; 7(1):111. PMC: 5676570. DOI: 10.1186/s13613-017-0335-9. View

16.

. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

17.

Na S, Chung C, Choi H, Cho Y, Yang J, Suh G . Blood Stream Infection in Patients on Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. Infect Control Hosp Epidemiol. 2018; 39(7):871-874. DOI: 10.1017/ice.2018.90. View

18.

Dobner J, Kaser S . Body mass index and the risk of infection - from underweight to obesity. Clin Microbiol Infect. 2017; 24(1):24-28. DOI: 10.1016/j.cmi.2017.02.013. View

19.

Raad I, Hanna H, Maki D . Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007; 7(10):645-57. DOI: 10.1016/S1473-3099(07)70235-9. View

20.

Harpsoe M, Nielsen N, Friis-Moller N, Andersson M, Wohlfahrt J, Linneberg A . Body Mass Index and Risk of Infections Among Women in the Danish National Birth Cohort. Am J Epidemiol. 2016; 183(11):1008-17. DOI: 10.1093/aje/kwv300. View